TBIQYR4258-Global G-Protein Coupled Receptor (GPCR) Targeting Market Research Report 2019

                                          
G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein. 

The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.

In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%. 

North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%. 

Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. 


The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 79 million US$ in 2018 is expected to reach 100 million US$ by the end of 2025, growing at a CAGR of 2.6% during 2019-2025.
This report focuses on G-Protein Coupled Receptor (GPCR) Targeting volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-Protein Coupled Receptor (GPCR) Targeting market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Thermo Fisher Scientific
    PerkinElmer
    Merck
    BD Biosciences
    Molecular Devices
    Promega
    Qiagen
    Abcam
    Corning
    Cisbio
    Discoverx
    Enzo Life Sciences

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    GPCR Consumables
    GPCR Equipment

Segment by Application
    Oncology
    Cardiovascular System
    Central Nervous System
    Other